The purpose of this study was to assess the safety, tolerability and efficacy of AR101 peanut oral immunotherapy over an extended dosing period. Further information can be accessed here.

The purpose of this study was to demonstrate efficacy of the House Dust Mite SLIT-tablet compared to placebo in children (5-11 years of age) with House Dust Mite allergic rhinitis. It also assessed safety and tolerability of the treatment, and assess whether treatment has an impact on asthma symptoms and medication use, immunological parameters, and rhinoconjunctivitis quality of life (QoL). Further information can be accessed here.

The purpose of this study was to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis. Further information can be accessed here.

The purpose of this study was to demonstrate the efficacy of dupilumab in adult and adolescent participants with primary acquired chronic inducible cold urticaria (ColdU) who remain symptomatic despite the use of an H1-antihistamine. Further information can be accessed here.

The purpose of this trial was to evaluate the safety and efficacy of delgocitinib cream towards treating adult patients with chronic hand eczema. Further information can be found here.

The purpose of this study was to assess how delgocitinib cream works to treat CHE when compared to a placebo cream with no active substance. Further information can be found here.

The purpose of this trial was to evaluate the safety and efficacy of delgocitinib cream towards treating pediatric and adult patients with moderate to severe atopic dermatitis. Further information can be found here.

The purpose of this study was to:

Part A:

To determine the treatment effect of dupilumab compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as assessed by histological and clinical measures and to inform/confirm the final sample size determination for Part B.

Part B:
To demonstrate the efficacy of dupilumab treatment compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as assessed by histological and clinical measures.

Part C:
To assess the safety and efficacy of dupilumab treatment in adult and adolescent patients with EoE after up to 52 weeks of treatment as assessed by histological and clinical measures.

Further information can be accessed here.

The purpose of this study was to assess the tolerability of peanut protein in pediatric patients (6-17 years old) treated with dupilumab monotherapy. Further information can be accessed here.

The purpose of this study was to assess the efficacy and safety of benralizumab-mediated eosinophil depletion for treating patients with chronic rhinosinusitis with nasal polyps. Further information can be accessed here.

The purpose of this trial was to test if treatment with tralokinumab can affect the body's immune response to vaccines. The trial also evaluated the efficacy of tralokinumab when it was given with vaccines. The final trial article is linked here and further information can be accessed here.